Best Research Article Award
Koteswara Rao Yerra
Texas A&M University, United States
| Koteswara Rao Yerra |
| Affiliation |
Texas A&M University |
| Country |
United States |
| Scopus ID |
7201581139 |
| Documents |
90 |
| Citations |
4,645 |
| h-index |
41 |
| Subject Area |
Engineering |
| Event |
Global Innovation Technologist Awards |
| ORCID |
0000-0001-6063-904X |
Koteswara Rao Yerra is a researcher associated with Texas A&M University whose scholarly record spans engineering and interdisciplinary research areas. The profile presented for the Best Research Article Award considers publication activity, citation performance, research continuity, and recent article-level contributions. The available publication record includes work addressing antimicrobial photodynamic therapy, microbial infection mechanisms, oxidative stress, and bioactive compounds, illustrating engagement with research questions that connect engineering-oriented methods with biomedical and molecular applications.[1]
Abstract
This article summarizes the academic profile and recent publication contributions of Koteswara Rao Yerra in relation to the Best Research Article Award. Particular attention is given to recent studies concerning antimicrobial photodynamic therapy against Klebsiella pneumoniae, the enhancement of antibiotic activity, inflammatory mechanisms in Neisseria gonorrhoeae-infected macrophages, and investigations involving bioactive compounds. These publications demonstrate a continuing interest in scientifically defined therapeutic and mechanistic research problems.[2][3]
Keywords
Antimicrobial photodynamic therapy; Klebsiella pneumoniae; photosensitizers; antibiotics; NLRP3 inflammasome; oxidative stress; bioactive compounds; engineering research.
Introduction
Research article recognition commonly evaluates the quality, relevance, originality, and documented scholarly influence of published work. Within this context, Yerra’s recent publications address antimicrobial resistance and infection-related biological processes through experimental approaches involving light-activated therapeutic strategies and combined treatment modalities. Such topics remain relevant to interdisciplinary research because they connect technological intervention with microbiological and pharmacological investigation.[2]
Research Profile
The available Scopus profile identifies 90 documents, 4,645 citations, and an h-index of 41. These indicators provide a quantitative overview of publication output and citation visibility, while the ORCID record supports persistent researcher identification across scholarly information systems.[1]
Research Contributions
A recent contribution examines dual-photosensitizer antimicrobial photodynamic therapy and its combination with antibiotics against Klebsiella pneumoniae. Related work investigates methylene blue and Photodithazine as combined photosensitizers and evaluates approaches intended to enhance antibiotic effects through photodynamic treatment.[2][3][4]
Publications
- Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics, Pharmaceutics (2026).
- Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response, Journal of Traditional and Complementary Medicine (2026).
- The Combined Photosensitizers in Antimicrobial Photodynamic Therapy, International Journal of Molecular Sciences (2025).
- Enhancing Antibiotic Effect by Photodynamic, Antibiotics (2025).
Research Impact
Citation indicators suggest sustained visibility across the documented publication record. An h-index of 41, together with 4,645 citations, provides evidence of repeated citation to a substantial portion of the researcher’s indexed work. These metrics are descriptive indicators and should be interpreted alongside publication quality, disciplinary context, collaboration patterns, and the specific contribution of individual articles.[1]
Award Suitability
The profile is suitable for consideration under the Best Research Article Award category because it combines an established indexed publication record with recent article contributions addressing defined scientific problems. The antimicrobial photodynamic therapy studies provide a focused example of research examining alternative or complementary approaches to bacterial treatment, while related mechanistic work broadens the documented scope of investigation.[2][5]
Conclusion
Koteswara Rao Yerra’s documented academic profile reflects a combination of publication productivity, citation impact, and recent research activity. The selected articles demonstrate continued engagement with antimicrobial treatment strategies, inflammatory response mechanisms, and bioactive compounds. Taken together, these elements provide a structured basis for academic recognition within the Global Innovation Technologist Awards framework.
External Links
References
- Elsevier. (n.d.). Scopus author details: Koteswara Rao Yerra, Author ID 7201581139. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7201581139
- Yerra, K. R., et al. (2026). Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics: A New Investigation Modality Against Klebsiella pneumoniae.
https://doi.org/10.3390/pharmaceutics18050587
- Yerra, K. R., et al. (2025). The Combined Photosensitizers in Antimicrobial Photodynamic Therapy: The Case of Methylene Blue and Photodithazine Against Klebsiella pneumoniae. International Journal of Molecular Sciences.
https://doi.org/10.3390/ijms262010211
- Yerra, K. R., et al. (2025). Enhancing Antibiotic Effect by Photodynamic: The Case of Klebsiella pneumoniae. Antibiotics.
https://doi.org/10.3390/antibiotics14080766
- Yerra, K. R., et al. (2026). Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response by reducing oxidative stress in Neisseria gonorrhoeae-infected macrophages. Journal of Traditional and Complementary Medicine.
https://doi.org/10.1016/J.JTCME.2025.06.003